These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Ovulation induction with a combination of LHRH analogue and hMG pulsatile subcutaneous administration in PCO patients]. Nakamura Y; Yoshimura Y; Tamaoka Y; Yamada H; Iizuka R; Suzuki M Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2157-64. PubMed ID: 3123581 [TBL] [Abstract][Full Text] [Related]
23. [Suppression of endogenous LH increase in ovarian stimulation with the GnRH antagonist Cetrorelix]. Diedrich K; Diedrich C; Santos E; Bauer O; Zoll C; al-Hasani S; Reissmann T; Krebs D; Klingmüller D Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):237-40. PubMed ID: 8013860 [TBL] [Abstract][Full Text] [Related]
24. In vitro fertilisation. A review of drug therapy and clinical management. Jennings JC; Moreland K; Peterson CM Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126 [TBL] [Abstract][Full Text] [Related]
25. [The significance of specific LH patterns before and following ovulation induction with hCG within the scope of in vitro fertilization and simplified diagnosis]. Zech H; Weiss P; Zerlauth M; Fritzsche H Geburtshilfe Frauenheilkd; 1988 Jun; 48(6):404-8. PubMed ID: 2458294 [TBL] [Abstract][Full Text] [Related]
26. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Diedrich K; Diedrich C; Santos E; Zoll C; al-Hasani S; Reissmann T; Krebs D; Klingmüller D Hum Reprod; 1994 May; 9(5):788-91. PubMed ID: 7929723 [TBL] [Abstract][Full Text] [Related]
27. Outcomes after early or midfollicular phase LH supplementation in previous inadequate responders. Sönmezer M; Iltemir Duvan C; Ozmen B; Taşçi T; Ozkavukçu S; Atabekoğlu CS Reprod Biomed Online; 2010 Mar; 20(3):350-7. PubMed ID: 20093082 [TBL] [Abstract][Full Text] [Related]
28. Combined GnRH-agonist/gonadotrophin stimulation for in-vitro fertilization. Schmutzler RK; Reichert C; Diedrich K; Wildt L; Diedrich C; Al-Hasani S; van der Ven H; Krebs D Hum Reprod; 1988 Oct; 3 Suppl 2():29-33. PubMed ID: 2976414 [TBL] [Abstract][Full Text] [Related]
29. Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Olivennes F; Fanchin R; Bouchard P; Taïeb J; Selva J; Frydman R Hum Reprod; 1995 Jun; 10(6):1382-6. PubMed ID: 7593501 [TBL] [Abstract][Full Text] [Related]
30. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles. Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187 [TBL] [Abstract][Full Text] [Related]
31. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Beckers NG; Laven JS; Eijkemans MJ; Fauser BC Hum Reprod; 2000 Jan; 15(1):43-9. PubMed ID: 10611186 [TBL] [Abstract][Full Text] [Related]
32. The impact of LH-containing gonadotropin stimulation on euploidy rates in preimplantation embryos: antagonist cycles. Weghofer A; Munné S; Brannath W; Chen S; Barad D; Cohen J; Gleicher N Fertil Steril; 2009 Sep; 92(3):937-942. PubMed ID: 18774557 [TBL] [Abstract][Full Text] [Related]
33. The value of GnRH analogue therapy in IVF in women with unexplained infertility. Ashkenazi J; Dicker D; Feldberg D; Goldman GA; Yeshaya A; Goldman JA Hum Reprod; 1989 Aug; 4(6):667-9. PubMed ID: 2528570 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve. Chou LL; Hwu YM; Lin MH; Lin SY; Lee RK Taiwan J Obstet Gynecol; 2010 Dec; 49(4):442-8. PubMed ID: 21199746 [TBL] [Abstract][Full Text] [Related]
35. Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer. Kreiner D; Droesch K; Itskovitz J; Liu HC; Navot D; Rosenwaks Z J In Vitro Fert Embryo Transf; 1988 Oct; 5(5):265-7. PubMed ID: 3148022 [TBL] [Abstract][Full Text] [Related]
36. Delayed occurrence of an LH surge after HCG administration during ovarian stimulation with gonadotrophins: effect of LHRH treatment. Rojas FJ; Moretti-Rojas I; Balmaceda JP; Asch RH Hum Reprod; 1989 Aug; 4(6):643-6. PubMed ID: 2506219 [TBL] [Abstract][Full Text] [Related]
37. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. III. Proteoglycans. Franchimont P; Hazee-Hagelstein MT; Hazout A; Gysen P; Salat-Baroux J; Schatz B; Demerle F Biol Reprod; 1990 Aug; 43(2):183-90. PubMed ID: 2143088 [TBL] [Abstract][Full Text] [Related]
38. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328 [TBL] [Abstract][Full Text] [Related]
39. [Analogs of GnRH and fertilization in vitro. Value of the use of GnRH analogs in the stimulation and monitoring of ovulation for fertilization in vitro]. Vauthier D; Lefebvre G J Gynecol Obstet Biol Reprod (Paris); 1987; 16(8):1075-8. PubMed ID: 2967320 [TBL] [Abstract][Full Text] [Related]
40. Gonadotropin stimulation after pituitary desensitization with leuprolide acetate, comparison of FSH/hMG and hMG alone cycles--a study of 166 cases. Hwang FR; Chang MY; Soong YK Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):223-30. PubMed ID: 8313205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]